Evidence map›Paper›PMID 30533576›Full record

ArticleACS omega2018

Synthesis and Evaluation of Troponoids as a New Class of Antibiotics.

Feng Cao, Cari Orth, Maureen J Donlin, Patrick Adegboyega, Marvin J Meyers, Ryan P Murelli, Mohamed Elagawany, Bahaa Elgendy, John E Tavis

Abstract read
In one paragraph

Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Nanomaterials (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Effects of Troponoids on Mitochondrial Function and Cytotoxicity.Antimicrobial agents and chemotherapy · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. HBV replication inhibitors.Antiviral research · 2020
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Feng CaoJohn Cochran Division, Department of Veterans Affairs Medical Center, 915 North Grand Blvd., St. Louis, Missouri 63106, United States.
Cari OrthJohn Cochran Division, Department of Veterans Affairs Medical Center, 915 North Grand Blvd., St. Louis, Missouri 63106, United States.
Maureen J DonlinEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri 63104, United States.
Patrick AdegboyegaJohn Cochran Division, Department of Veterans Affairs Medical Center, 915 North Grand Blvd., St. Louis, Missouri 63106, United States.
Marvin J MeyersDepartment of Chemistry, Saint Louis University, St. Louis, Missouri 63104, United States.
Ryan P MurelliDepartment of Chemistry, Brooklyn College, The City University of New York, Brooklyn, New York 11210, United States.
Mohamed ElagawanyCenter for Clinical Pharmacology, Washington University School of Medicine and St. Louis College of Pharmacy, St. Louis, Missouri 63110, United States.
Bahaa ElgendyCenter for Clinical Pharmacology, Washington University School of Medicine and St. Louis College of Pharmacy, St. Louis, Missouri 63110, United States.
John E TavisDepartment of Molecular Microbiology and Immunology, The Saint Louis University Liver Center, Saint Louis University School of Medicine, St. Louis, Missouri 63104, United States.

Funding

Optimization of alpha-hydroxytropolones as novel inhibitors of the HBV RNaseHR01AI122669 · NIAID · SAINT LOUIS UNIVERSITY · PI TAVIS, JOHN E · 2016 to 2020
$2.2M
A screen for antiviral compounds targeting the Hepatitis B Virus ribonuclease HR01AI104494 · NIAID · SAINT LOUIS UNIVERSITY · PI TAVIS, JOHN E · 2014 to 2016
$1.0M
NIAID NIH HHS R01 AI104494NIAID NIH HHS R01 AI122669
6 · The paper itself

Abstract

Novel antibiotics are urgently needed. The troponoids [tropones, tropolones, and α-hydroxytropolones (α-HT)] can have anti-bacterial activity. We synthesized or purchased 92 troponoids and evaluated their antibacterial activities against

Identifiers

PMID30533576
PMCPMC6275967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.